Document is current

Article History

Received: 28 April 2026

Accepted: 20 July 2026

First Online: 18 August 2026

Declarations

Conflict of Interest: Ruriko Koto, Shiori Yoshida, and Akihiro Nakajima are employees of Teijin Pharma Limited and hold stock in Teijin Limited. Ken Sugimoto has received payment for presentations from Sumitomo Pharma Co., Ltd., and Daiichi Sankyo Co., Ltd.

Ethical Approval: The present study used fully anonymized data; therefore, informed consent from individual patients and institutional review board approval were not required. The datasets were purchased from DeSC Healthcare Inc., and authorization was obtained to use the data for research purposes and publish the results.

Patient Participants: We thank all participants whose data were included in the database used in this study.

Patient Involvement: As this was an observational study using an existing database, patients were not involved in the design, conduct, analysis, interpretation, or reporting of the study. We gratefully acknowledge the contributions of all patients whose data were included in the database used for this analysis.